# TASK A04: EVALUATION OF THERAPEUTICS IN MOUSE MODELS OF DENGUE VIRUS

> **NIH NIH N01** · UNIVERSITY OF TEXAS MED BR GALVESTON · 2021 · $316,646

## Abstract

This contract provides for the development and standardization of small animal models of infectious diseases, and may include efficacy testing of candidate products, including GLP studies to support licensure.

## Key facts

- **NIH application ID:** 10388065
- **Project number:** 272201700040I-P00004-27200006-1
- **Recipient organization:** UNIVERSITY OF TEXAS MED BR GALVESTON
- **Principal Investigator:** DAVID BEASLEY
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $316,646
- **Award type:** —
- **Project period:** 2017-11-01 → 2021-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10388065

## Citation

> US National Institutes of Health, RePORTER application 10388065, TASK A04: EVALUATION OF THERAPEUTICS IN MOUSE MODELS OF DENGUE VIRUS (272201700040I-P00004-27200006-1). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10388065. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*